ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch
By filer · By stock

$ARQT:NASDAQ · Arcutis Biotherapeutics Inc - US

Sector: health

Conviction from: NASDAQCitrini

52-week range: 15.1031.77

Dermatology-focused biopharma

2 tracked filer(s) hold this · 1 opened, 0 added, 1 trimmed in 30-JUN-2026

Aggregate 13FScore 72 — mean of 2 scored holder(s) · buyers (new/add) avg 63. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Paul Tudor Jones / Tudor63New buy131,914$3,458,7850.0%
Steve Cohen / Point7280Trimmed -39%362,449$9,503,4130.0%

Beyond 13F — activists, insiders, politicians & research

Congressional trades all politician trades →

3 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-05-29Gilbert Cisneros CA31BUY$1,001 - $15,000PTR
2026-03-03Gilbert Cisneros CA31BUY$1,001 - $15,000PTR
2025-12-11Gilbert Cisneros CA31SELL$1,001 - $15,000PTR

Citrini Research coverage report library →

ReportDateStance
#113 — 26 Trades for 2026: A Thematic Watchlist for the New Year2025-12-17LONG
#97 — Rough Seas Make Strong Sailors: Navigating the Healthcare Policy Tsunami2025-05-28LONG

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-08-17.